Status: Not yet recruiting
Safety, PK, and PD of BSA204 in Chinese Adults With Borderline Elevated Lipoprotein(a)
The purpose of this Phase 1 clinical study is to evaluate the safety and tolerability of a single dose of BSA204 injection in Chinese adults with borderline high levels of lipoprotein(a) \[Lp(a)\].
Participants needed: 40
Trial details
Phase: Phase 1Age: 18-55Biological sex: AllType: InterventionalSponsor: Bisirna Therapeutics (Suzhou) Co., Ltd.Updated: Apr 28, 2026Locations: 2
Eligibility criteria
Body mass index (BMI) 18 to 30 kg/m2 [+4]
Pregnant or lactating women. [+4]